Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2017 03:05 ET | Source: PreveCeutical Medical Inc

PreveCeutical™ Medical Inc. Announces Preliminary Results from Phase One of its Venom Re-Engineering Project

VANCOUVER, British Columbia, Aug. 11, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces encouraging results from the Research and...